MMP9 and cancer: Treatment of cells with 20 μM AC-73, a specific inhibitor for CD147 (34), decreased the amount of MMP1 and MMP9 (Fig. S3, C and D), confirming that the CD147-MMPs signaling is conserved in HT-1080 cells as in the majority of cancer cells.